Structure Therapeutics Inc.

GPCR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001888886

SEC filings (opens in a new tab)

No open-market purchases or sales by Structure Therapeutics Inc. insiders were filed in the last 90 days; 191 institutions reported holding it in 13F filings for Q2 2026, worth $3.62B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Structure Therapeutics Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of GPCR: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	161	2	165	+6
Shares	61.6M	10.5K	60.9M	−620.5K (−1.0%)
Value	$2.69B	$460.2K	$1.65B	−$1.04B (−38.7%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Structure Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to GPCR in Q4 2024
Institution	Shares	Value	% of portfolio
Catalio Capital Management, LP	569,395	$15.4M	3.38%
Boxer Capital Management, LLC	500,000	$13.6M	1.15%
Foresite Capital Management VI LLC	420,000	$11.4M	5.08%
Camber Capital Management LP	300,000	$8.14M	0.32%
Handelsbanken Fonder AB	165,000	$4.47M	0.02%
CCG Wealth Management, LLC	150,000	$4.07M	2.27%
Universal- Beteiligungs- und Servicegesellschaft mbH	113,992	$3.09M	0.01%
Alps Advisors Inc	46,300	$1.26M	0.01%
Tema ETFs LLC	44,343	$1.20M	0.50%
ADAR1 Capital Management, LLC	35,319	$957.9K	0.20%
Mariner, LLC	24,530	$665.3K	0.00%
J. Goldman & Co LP	16,873	$457.6K	0.02%
Walleye Capital LLC	11,656	$316.1K	0.00%
BNP Paribas Arbitrage, SA	11,218	$304.2K	0.00%
PEAK6 LLC	9,445	$256.1K	0.01%
Spire Wealth Management	8,949	$242.7K	0.01%
Vestcor Inc	4,700	$127.0K	0.00%
Headlands Technologies LLC	4,160	$112.8K	0.01%
FNY Investment Advisers, LLC	1,500	$40.0K	0.02%
GF Fund Management Co. Ltd.	1,251	$33.9K	0.00%
R Squared Ltd	680	$18.4K	0.02%
Clear Street Markets LLC	246	$6.67K	0.00%
Caitong International Asset Management Co., Ltd	186	$5.04K	0.00%
CWM, LLC	100	$3.00K	0.00%
Vermillion Wealth Management, Inc.	100	$2.71K	0.00%
CoreCap Advisors, LLC	77	$2.09K	0.00%
Aventura Private Wealth, LLC	28	$759	0.00%
Global Retirement Partners, LLC	10	$271	0.00%
Point72 Asia (Singapore) Pte. Ltd.	1	$23	0.00%

Sold out (23)

Institutions that held Structure Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of GPCR in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Octagon Capital Advisors LP	1,198,000	$52.6M
T. Rowe Price Investment Management, Inc.	715,968	$31.4M
Avidity Partners Management LP	430,900	$18.9M
Boxer Capital, LLC	400,000	$17.6M
Adage Capital Partners GP, L.L.C.	250,000	$11.0M
Tang Capital Management LLC	144,500	$6.34M
Hudson Bay Capital Management LP	71,615	$3.14M
Altium Capital Management LP	70,000	$3.07M
Blue Owl Capital Holdings LP	65,000	$2.85M
Plustick Management LLC	45,000	$1.98M
Y-Intercept (Hong Kong) Ltd	40,706	$1.79M
Perceptive Advisors LLC	34,852	$1.53M
Gsa Capital Partners LLP	30,464	$1.34M
AlphaCentric Advisors LLC	26,000	$1.14M
Verition Fund Management LLC	16,703	$733.1K
XTX Topco Ltd	11,938	$524.0K
Alyeska Investment Group, L.P.	7,660	$336.2K
Shay Capital LLC	7,500	$329.2K
Gilbert & Cook, Inc.	5,682	$249.4K
Crestline Management, LP	5,310	$233.1K
Squarepoint Ops LLC	5,163	$226.6K
Dearborn Partners LLC	4,600	$201.9K
Truvestments Capital LLC	82	$3.60K

Not filed for Q4 2024 yet (2)

Institutions that held Structure Therapeutics Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GPCR in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
PEAK6 Investments LLC	10,445	$458.4K
Planning Capital Management Corp	40	$1.76K